In this issue:
- CV complications and mortality in youth-onset type 1 or 2 diabetes
- At-home self-screening for type 2 diabetes: feasibility and cost effectiveness
- Cardiometabolic changes by weight regain after withdrawal of tirzepatide for obesity
- Pharmacists improved safe prescribing for high-risk type 2 diabetes
- Temporal changes and genetic susceptibility to type 2 diabetes
- Diabetes-related antibody requesting in NZ primary and secondary care
- Cost effectiveness of real-time CGM vs. SMBG in insulin-treated type 2 diabetes
- Diabetes remission after efsubaglutide alfa for type 2 diabetes
- Physical activity patterns and CV disease risk in overweight/obesity
- Rapid post partum progression to diabetes following early antenatal prediabetes
Please login below to download this issue (PDF)